Cargando…
Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer
A kinetic enzyme-linked immunosorbent assay (ELISA) for plasma tissue inhibitor of metalloproteinase (TIMP)-1 was developed in order to examine the potential diagnostic and prognostic value of TIMP-1 measurements in cancer patients. The ELISA enabled specific detection of total TIMP-1 in EDTA, citra...
Autores principales: | Holten-Andersen, M N, Murphy, G, Nielsen, H J, Pedersen, A N, Christensen, I J, Høyer-Hansen, G, Brünner, N, Stephens, R W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362309/ https://www.ncbi.nlm.nih.gov/pubmed/10408859 http://dx.doi.org/10.1038/sj.bjc.6690384 |
Ejemplares similares
-
Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas
por: Groft, L L, et al.
Publicado: (2001) -
Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients
por: Aaberg-Jessen, Charlotte, et al.
Publicado: (2016) -
Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies
por: Holst-Hansen, C, et al.
Publicado: (1999) -
Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3
por: Baker, A H, et al.
Publicado: (1999) -
Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma
por: Salmela, M T, et al.
Publicado: (2001)